133 related articles for article (PubMed ID: 36506579)
1. Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries.
Owusu-Asante M; Darko DM; Walker S; Salek S
Front Pharmacol; 2022; 13():1069345. PubMed ID: 36506579
[No Abstract] [Full Text] [Related]
2. Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry.
Owusu-Asante M; Darko DM; Walker S; Salek S
Front Pharmacol; 2023; 14():1184108. PubMed ID: 37229251
[No Abstract] [Full Text] [Related]
3. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward.
Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
Front Pharmacol; 2022; 13():891506. PubMed ID: 35865962
[No Abstract] [Full Text] [Related]
4. What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements.
Miletic N; Adam S; Acquah J; Aziz Z; Joos A; Mwangi JM
Front Med (Lausanne); 2023; 10():1207954. PubMed ID: 37731723
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement.
Ngum N; Mashingia J; Ndomondo-Sigonda M; Walker S; Salek S
Front Pharmacol; 2022; 13():1031289. PubMed ID: 36408267
[No Abstract] [Full Text] [Related]
6. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
[TBL] [Abstract][Full Text] [Related]
7. Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.
Ndomondo-Sigonda M; Azatyan S; Doerr P; Agaba C; Harper KN
PLOS Glob Public Health; 2023; 3(4):e0001651. PubMed ID: 37186241
[TBL] [Abstract][Full Text] [Related]
8. Industrial perceptions of medicines regulatory harmonization in the East African Community.
Dansie LS; Odoch WD; Årdal C
PLoS One; 2019; 14(6):e0218617. PubMed ID: 31216323
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
Sithole T; Mahlangu G; Walker S; Salek S
Front Med (Lausanne); 2022; 9():898725. PubMed ID: 35547215
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward.
Sithole T; Mahlangu G; Walker S; Salek S
Front Med (Lausanne); 2022; 9():898743. PubMed ID: 35547217
[TBL] [Abstract][Full Text] [Related]
11. Regulatory performance of the East African Community joint assessment procedure: The way forward for regulatory systems strengthening.
Mashingia J; Ngum N; Ndomondo-Sigonda M; Kermad A; Bujar M; Salek S; Walker S
Regul Toxicol Pharmacol; 2023 May; 140():105383. PubMed ID: 36933643
[TBL] [Abstract][Full Text] [Related]
12. Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency.
Ngum N; Ndomondo-Sigonda M; Walker S; Salek S
Regul Toxicol Pharmacol; 2023 Dec; 145():105497. PubMed ID: 37778434
[TBL] [Abstract][Full Text] [Related]
13. Medicines Regulation in Africa: Current State and Opportunities.
Ndomondo-Sigonda M; Miot J; Naidoo S; Dodoo A; Kaale E
Pharmaceut Med; 2017; 31(6):383-397. PubMed ID: 29200865
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward.
Sithole T; Mahlangu G; Capote V; Sitoie T; Shifotoka S; Gaeseb J; Padayachee S; Sehloho T; Khea A; Fimbo A; Munkombwe Z; Mwale B; Salek S; Walker S
Front Med (Lausanne); 2021; 8():742181. PubMed ID: 34513893
[No Abstract] [Full Text] [Related]
15. Establishment of the African Medicines Agency: progress, challenges and regulatory readiness.
Ncube BM; Dube A; Ward K
J Pharm Policy Pract; 2021 Mar; 14(1):29. PubMed ID: 33685518
[TBL] [Abstract][Full Text] [Related]
16. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa.
Narsai K; Williams A; Mantel-Teeuwisse AK
South Med Rev; 2012 Jul; 5(1):31-7. PubMed ID: 23093897
[TBL] [Abstract][Full Text] [Related]
17. Assessment of pharmacovigilance guidelines in the Southern African Development Community: A document review.
Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5755. PubMed ID: 38362654
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Performance of the Gulf Cooperation Council Centralised Regulatory Review Process: Strategies to Improve Product Authorisation Efficiency and Quality.
Hashan HM; Al-Muteb SK; Alismail IA; Alsaleh ON; Alkherb ZM; McAuslane N; Walker SR
Pharmaceut Med; 2022 Aug; 36(4):223-231. PubMed ID: 35767216
[TBL] [Abstract][Full Text] [Related]
19. Primary Care Research Team Assessment (PCRTA): development and evaluation.
Carter YH; Shaw S; Macfarlane F
Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028
[TBL] [Abstract][Full Text] [Related]
20. The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies.
Ncube BM; Dube A; Ward K
Health Policy Plan; 2024 May; 39(5):447-456. PubMed ID: 38497780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
